|
Mylan Inc. (NYSE-Listed MYL) visits the NYSE to celebrate its recent acquisition of Merck Generics. In honor of the occasion, Vice Chairman & CEO Robert J. Coury rings The Closing Bell®.
Click the link below to view an archived webcast of The Closing Bell.
 Windows Media Player 300k
Mylan Inc.
Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.
|
